Help us: Donate
Follow us on:
×

Tag: Ending Age-Related Diseases 2020

September 25, 2020
In this interview at Ending Age-Related Diseases 2020, Elena Milova of Lifespan.io and Daria Khaltourina of the International Longevity Alliance discuss whether or not aging should be considered a disease by the World Health Organization, and what its classification means to the medical community, longevity advocates, and the general public. Daria also talks about the...
September 18, 2020
In this interview at Ending Age-Related Diseases 2020, Steve Hill of Lifespan.io discusses the longevity of humanity with David Wood of the London Futurists. The topics include the public opinion of people who seek longevity; accelerating technology in respect to aging; ways of gaining mainstream appeal, such as humanitarian and economic arguments; his book on...
September 11, 2020
In this interview at Ending Age-Related Diseases 2020, Elena Milova of Lifespan.io asks Michael Greve of the Forever Healthy Foundation about his history in investigating age-related diseases, his donations to organizations that fight against aging, his recent analytical initiative, Rejuvenation Now, in determining effective therapies against age-related diseases, and his other efforts in fighting against...
September 09, 2020
In his presentation at Ending Age-Related Diseases 2020, investor Sergey Young discussed the potential of a trillion-dollar market, proactive versus reactive medicine, demographic changes throughout the world, technology integration, the potential of regenerative medicine, the role of capital in rejuvenation biotechnology, and many other related topics.
September 09, 2020
In this panel discussion from Ending Age-Related Diseases 2020, Elena Milova of Lifespan.io, Roey Tzezana of XPRIZE, and Maria Entraigues Abramson of SENS Research Foundation discuss what the public knows about the field of rejuvenation biotechnology and how it perceives this field, along with public opinion on longevity in general.
September 04, 2020
At Ending Age-Related Diseases 2020, Dr. Brian Kennedy of the National University of Singapore discussed the aging population of Singapore, the need for comprehensive healthcare, alpha-ketoglutarate (AKG) and its effects against frailty in mice, ongoing trials of ketoglutarate in humans, spermidine against obesity, the role of biomarkers, and the importance of keeping people well rather...